Guan, X., Wang, L., Cao, Y., Shi, F., Xu, H., Ding, J., Wu, M., & Li, H. (2023). A Erratum on Cost effectiveness analysis of blonanserin versus ziprasidone as first-line treatment for patients with schizophrenia in China. Health Decision, 1. https://doi.org/10.54844/hd.2023.0498